
Gland Pharma
NSE: GLAND | BSE: 543245
50% Sell
₹1,419.30
+₹15.80 (1.13%) TodayLast updated on 05 May, 2025 | 15:41 ISTMarket cap | Open ₹1,400.60 | Prev. Close ₹1,403.50 |
Circuit range ₹1,684.20 - ₹1,122.80 | Day range ₹1,398.90 - ₹1,432.50 | Year range ₹1,277.80 - ₹2,220.95 |
Volume 96,032 | Avg. traded ₹1,419.14 | Revenue (12m) ₹5,729 Crs |
About Gland Pharma
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.
Gland Pharma Share Price Chart
Please wait...
Gland Pharma Fundamentals
Gland Pharma Key indicators
52 week high ₹2,220.95 | 52 week low ₹1,277.80 | P/E ratio 32.83 |
P/B ratio 2.59 | ROE 12.31% | ROCE 16.67% |
Dividend yield 1.42% | Debt/Equity ratio | EPS 63.34 |
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Sell40%
Hold
10%
Sell
50%
This analysis is based on the reviews of 10 experts in the last 7 days
Gland Pharma Financial Ratios
Operating profit margin37.8% | Net profit margin25.04% |
ROE12.31% | ROA11.39% |
ROCE16.67% |
Quick ratio7.99 | Current ratio11.04 |
Interest coverage180.2 | Asset turnover0.46 |
Debt to Equity0 |
P/E ratio32.83 | P/B ratio2.59 |
EV / EBITDA18.24 | |
Dividend yield1.42% |
Revenue statement
All values are in ₹ Crores (Cr)

Loading chart data
Cash flow
All values are in ₹ Crores (Cr)

Loading chart data
Balance sheet
All values are in ₹ Crores (Cr)

No data available at the moment
Total assets
Total liabilities
Gland Pharma Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Fri, May 2 2025 | ₹1,400.00 | ₹1,403.50 | |
Wed, Apr 30 2025 | ₹1,414.90 | ₹1,400.00 | -0.91% |
Tue, Apr 29 2025 | ₹1,422.00 | ₹1,412.90 | -0.01% |
Mon, Apr 28 2025 | ₹1,447.90 | ₹1,413.10 | -2.40% |
Fri, Apr 25 2025 | ₹1,470.40 | ₹1,447.90 | -1.20% |
Thu, Apr 24 2025 | ₹1,481.60 | ₹1,465.50 | -0.89% |
Wed, Apr 23 2025 | ₹1,456.00 | ₹1,478.70 | |
Tue, Apr 22 2025 | ₹1,460.00 | ₹1,450.90 | -0.92% |
Events
Corporate actions
Dividend • ₹20/share
Ex date 16 Aug 2024
More
Stocks Similar to Gland Pharma
Popular Stocks
Gland Pharma News
FAQs on Gland Pharma
What is the Gland Pharma share price today?
Gland Pharma share price is ₹ 1,419.30 as on 05 May, 2025 | 19:49 IST
What is today’s high & low share price of Gland Pharma?
Gland Pharma share price high: ₹ 1,432.50 and low: ₹ 1,398.90 as on 05 May, 2025 | 19:49 IST
What is the Gland Pharma share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 2,220.95 and Low Price is ₹ 1,277.80 as on 05 May, 2025 | 19:49 IST
What is the Gland Pharma Stock Symbol?
The Gland Pharma Stock symbol is GLAND.
Can I buy Gland Pharma shares on Holidays?
No, shares of Gland Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Gland Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.